Dipyrone 安乃近
CAS 68-89-3 MFCD00020783
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Alphabetic, Analytical Standards, Analytical/Chromatography, Chromatography, D, DIO - DIZ, Drugs & Metabolites, Forensic and Veterinary Standards, Neat Compounds
安全信息
GHS Symbol

- P342+P311
- P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
- P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
- H317 May cause an allergic skin reaction 可能导致皮肤过敏
- H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled 吸入可能导致过敏或哮喘症状或呼吸困难
- S36 Wear suitable protective clothing 穿戴适当的防护服;
- R42/43
TYPE OF TEST : TD - Toxic dose (other than lowest) ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 792 mg/kg/78W-C TOXIC EFFECTS : Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors Liver - tumors REFERENCE : JJIND8 JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. Volume(issue)/page/year: 71,1295,1983
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 536 mg/kg/78W-C TOXIC EFFECTS : Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors Liver - tumors REFERENCE : JJIND8 JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. Volume(issue)/page/year: 71,1295,1983
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 2891 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 24,600,1974
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 3 gm/kg TOXIC EFFECTS : Behavioral - altered sleep time (including change in righting reflex) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - respiratory depression REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 21,719,1971
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 1625 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : RPTOAN Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- Volume(issue)/page/year: 51,183,1988
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Unreported SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 2750 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : JDGRAX Journal of Drug Research. (National Organization for Drug Research and Control, POB 29, Cairo, Egypt) V.2- 1969- Vol
TYPE OF TEST : DNA repair TEST SYSTEM : Bacteria - Bacillus subtilis DOSE/DURATION : 5 mg/disc REFERENCE : JNUDAT Journal of Nihon University School of Dentistry. (Nihon University School of Dentistry, 1-8-13 Surugadai, Kanda, Chiyoda-ku, Tokyo, 101, Japan) V.1- 1958- Volume(issue)/page/year: 34,183,1992
TYPE OF TEST : Mutation in microorganisms TEST SYSTEM : Bacteria - Salmonella typhimurium DOSE/DURATION : 1 mg/plate REFERENCE : AMONDS Applied Methods in Oncology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- Volume(issue)/page/year: 3,253,1980
TYPE OF TEST : Cytogenetic analysis ROUTE OF EXPOSURE : Oral TEST SYSTEM : Rodent - mouse DOSE/DURATION : 15600 ug/kg REFERENCE : CARYAB Caryologia. (Via G. LaPira 4, 50121 Florence, Italy) V.1- 1948- Volume(issue)/page/year: 36,385,1983
TYPE OF TEST : Cytogenetic analysis ROUTE OF EXPOSURE : Intraperitoneal TE
TYPE OF TEST : Cytogenetic analysis TEST SYSTEM : Human Lymphocyte DOSE/DURATION : 250 mg/L REFERENCE : SOGEBZ Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- Volume(issue)/page/year: 11,528,1975
TYPE OF TEST : Mutation test systems - not otherwise specified ROUTE OF EXPOSURE : Intraperitoneal TEST SYSTEM : Rodent - rat DOSE/DURATION : 1150 mg/kg REFERENCE : EJGCA9 Egyptian Journal of Genetics and Cytology. (Egyptian Soc. of Genetics, c/o Alexandria Univ., Faculty of Agriculture, Dept. of Genetics, Alexandria, Egypt) V.1- 1972- Volume(issue)/page/year: 11,105,1982
TYPE OF TEST : Cytogenetic analysis TEST SYSTEM
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE : 750 mg/kg SEX/DURATION : female 9 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - Central Nervous System REFERENCE : JMTHBU Journal of the Medical Association of Thailand. (Businesss Mgr., Dept. of Microbiology, Faculty of Medicine, Siriraj Hospital, Bangkok 7, Thailand) V.1- 1918- Volume(issue)/page/year: 53,550,1973
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human - woman DOSE : 30 mg/kg SEX/DURATION : lactating female 41 day(s) post-birth TOXIC EFFECTS : Reproductive - Effects on Newborn - other neonatal measures or effects REFERENCE : HUTODJ Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1- 1981- Volume(issue)/page/year: 3,505,1984
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE : 1 gm/kg SEX/DURATION : female 9 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) REFERENCE : JMTHBU Journal of the Medical Association of Thailand. (Businesss Mgr., Dept. of Microbiology, Faculty of Medicine, Siriraj Hospital, Bangkok 7, Thailand) V.1- 1918- Volume(issue)/page/year: 53,550,1973
其他信息
- 储运特性:库房通风低温干燥
- 上游原料:亚硫酸氢钠
- 毒性分级:中毒
- 可燃性危险特性:可燃;燃烧产生有毒氮氧化物,硫氧化物和氧化钠烟雾
- MOL 文件:68-89-3.mol
- Sigma Aldrich:68-89-3(sigmaaldrich)
- 灭火剂:干粉、泡沫、砂土、二氧化碳, 雾状水
- 用途一:有解毒、镇痛、抗风湿作用。主要用于退热,也用于急性关节炎、风湿性痛、肌肉痛、头痛等。
- 急性毒性:口服-大鼠 LD50: 3000 毫克/公斤;口服-小鼠LD50: 2891 毫克/公斤
- 安乃近的副作用:1,过敏、虚脱、白细胞减少、血小板减少,严重的可引起再生障碍性贫血. 2,肾毒性、胃肠道出血、严重皮疹,致死性粒细胞缺乏为其最严重副作用。
- 药品说明书:【别名】 安乃近 ,诺瓦经;罗瓦而精 ,罗瓦尔精,安替比林甲胺甲烷 【外文名】Metamizole Sodium, Analgin, Bonpyrin, Dipyron, Noramidopyrine, NOVALGIN 【性状】 本品为白色或黄白色的结晶或结晶性粉末,无臭,味微苦,易溶于水。 【作用】: 为氨基比林的衍生物,具有较显著的解热作用及较强的镇痛作用,解热作用为氨基比林的3倍,镇痛作用与氨基比林相似。 【体内过程】 口服易吸收,主要经肝脏代谢,肾脏排泄。 【适应症】 主要用于退热,亦用于急性关节炎、头痛、风湿性神经痛、牙痛、肌肉痛等。 【用法用量】 口服或滴鼻,口服成人每次0.5g,一日3次,儿童每次8-10mg/kg,必要时重复;滴鼻剂5岁以下每次每侧鼻孔1-2滴,必要时重复一次,5岁以上适当加量。 【注意事项】1、严格控制用量,以防虚脱。2、肌肉注射可致局部肌肉萎缩及糜烂,现已不用。 3、对吡喹酮类药有过敏史者禁用。 4、不宜长期使用,注意复查粒细胞。 【规格】 片剂,每片0.25g,0.5g;针剂,每支0.25g/1ml,0.5g/2ml;滴剂10-20%溶液
- 类别:有毒物品